AdvertisementAdvertise with NZME.
Latest fromBest of Business Analysis

<i>Fran O'Sullivan:</i> Year-end mailbag chock-full of surprises
Fran O'Sullivan takes a light-hearted look at the holiday letters that political and business leaders might have written.

<i>Anthony Doesburg:</i> Where rising tides are more than a future threat
Many nations fear rising water levels, but the Netherlands already has practical experience.

<i>Deborah Hill Cone:</i> Barbs, bemusements and bollockings
That's it then - another year of spouting, pronouncing and sticking the occasional spanner in the works.

<i>Yoke Har Lee:</i> Firm plays NZ drawcard to win drug trials
High standards and lower costs have helped to gain contracts from international pharmaceutical firms.